Neurocysticercosis and Population Movements: Analysis of 23 Imported Cases in Spain

  • C. Roca
  • J. Gascón
  • B. Font
  • T. Pujol
  • M. E. Valls
  • M. Corachán
Brief Report
First Online:

Keywords

Albendazole Praziquantel European Union Country Endemic Country Partial Epilepsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    World Health Organization (2002) World Health Organization fifty-fifth world health assembly A55/23. Provisional agenda item 13.18, 5 April 2002. Control of neurocysticercosis. http://www.who.int/gb/EB_WHA/PDF/WHA55/ea5523.pdfGoogle Scholar
  2. 2.
    Font Puig C, Puiz Postigo JA, Muñoz Batet C, Pardós Arnal F, Corachán Cuyás M (1999) Neurocisticercosis en España. A propósito de 4 casos observados en pacientes inmigrados de países endémicos. An Med Interna (Madrid) 16:89–91Google Scholar
  3. 3.
    Terraza S, Pujol T, Gascón J, Corachán M (2001) Neurocisticercosis: ¿una enfermedad importada?Med Clin (Barc) 116:261–263Google Scholar
  4. 4.
    López-Vélez R (2002) El fenómeno migratorio. Las cifras. In: Inmigración y salud. PBM, SL, MadridGoogle Scholar
  5. 5.
    Rousseau MC, Guillotel B, Delmont J (1999) Neurocysticercose dans le Sud-Est de la France entre 1988 et 1998. Presse Med 28:2141–2144PubMedGoogle Scholar
  6. 6.
    Shandera WX, White AC, Chen JC, Díaz P, Armstrong R (1994) Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine 73:37–52PubMedGoogle Scholar
  7. 7.
    Rosenfeld EA, Byrd SE, Shulman ST (1996) Neurocysticercosis among children in Chicago. Clin Infect Dis 23:262–268PubMedGoogle Scholar
  8. 8.
    Chatel G, Gulletta M, Scolari C, Bombana E, El-Hamad I, Matteelli A, Carosi G (1999) Neurocysticercosis in an italian traveler to Latin America. Am J Trop Med Hyg 60:255–256PubMedGoogle Scholar
  9. 9.
    Sanzón F, Osorio AM, Morales JP (2002) Serological screening for cisticercosis in mentally altered individuals. Trop Med Int Health 7:532–538CrossRefPubMedGoogle Scholar
  10. 10.
    Pal DK, Carpio A, Sander J (2000) Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 68:137–143CrossRefPubMedGoogle Scholar
  11. 11.
    Nicoletti A, Bartoloni A, Reggio A, Bartalesi F, Roselli M, Sofia V, Rosado J, Gamboa H, Paradisi F, Cancrini G, Tsang VCW, Hall AJ (2002) Epilepsy, cisticercosis, and toxocariasis. A population-based case-control study in rural Bolivia. Neurology 58:1256–1261PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • C. Roca
    • 1
  • J. Gascón
    • 2
  • B. Font
    • 3
  • T. Pujol
    • 4
  • M. E. Valls
    • 5
  • M. Corachán
    • 2
  1. 1.International Health Commission, Societat Catalana de Medicina Familiar i Comunitària, Àrea bàsica de Salut el ClotInstitut Català de la SalutBarcelonaSpain
  2. 2.Unit of Tropical Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic Universitari, Faculty of MedicineUniversity of BarcelonaBarcelonaSpain
  3. 3.Unit of Internal Medicine, Hospital Parc TaulíConsorci Sanitari de SabadellSabadellSpain
  4. 4.Unidad de RadiodiagnóticoHospital Clínic Universitari BarcelonaBarcelonaSpain
  5. 5.Microbiology Unit, Clinical Institute of Infectious Diseases and Immunology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic Universitari, Faculty of MedicineUniversity of BarcelonaBarcelonaSpain

Personalised recommendations